PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.\', \'Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt.\', \'Department of Microbiology and Biotechnology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt. Elbaz_pharmacy@yahoo.com.\', \'Hospitals of Zagazig University, Zagazig, Al Sharqia, 44519, Egypt.\', \'Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.\', \'Pharmacology Department, College of Veterinary Medicine, Suez Canal University, Ismailia, 41522, Egypt.\', \'Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, Al Sharqia, 44519, Egypt. gmetwa@bio.uni-kl.de.\', \'Department of Molecular Genetics, Faculty of Biology, Technical University of Kaiserslautern, Paul-Ehrlich Str. 24, 67663, Kaiserslautern, Germany. gmetwa@bio.uni-kl.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11356-021-16427-4
?:doi
?:hasPublicationType
?:journal
  • Environmental science and pollution research international
is ?:pmid of
?:pmid
?:pmid
  • 34562220
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • In silico screening of potent inhibitors against COVID-19 key targets from a library of FDA-approved drugs.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all